Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More

Clinical Trial: Unconscious Mind Training

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597603) titled 'Unconscious Mind Training' on May 13. Brief Summary: Phase I The core problem this clinica... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the pos... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More

Clinical Trial: Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596277) titled 'Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1... Read More

Clinical Trial: Remote Assesment of Functional Sequelae in Patients Operated for Congenital Syndactyly

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596862) titled 'Remote Assesment of Functional Sequelae in Patients Operated for Congenital Syndactyly' on N... Read More

Clinical Trial: Verbal Intent and Gaze Cues on Action Prediction in ASD

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597694) titled 'Verbal Intent and Gaze Cues on Action Prediction in ASD' on May 06. Brief Summary: A 2x2x3 ... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More

Clinical Trial: Telerehabilitation-Based Dance Therapy in Pediatric Cancer

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596745) titled 'Telerehabilitation-Based Dance Therapy in Pediatric Cancer' on May 13. Brief Summary: Child... Read More

• ««
• «
• 169053
• 169054
• 169055
• 169056
• 169057
• 169058
• 169059
• 169060
• 169061
• 169062
• »
• »»